Home Medical Devices Regulatory Affairs Outsourcing Market Size & Share Analysis , Outlook, Growth, Report to 2

Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Regulatory Consulting, Regulatory Writing and Publishing, Legal Representation, Product Registration and Clinical Trial Applications, Other Services, Speed Pedelecs), By Company Size (Small, Medium, Large), By Categories (Drugs, Biologics, Medical devices), By Product Stage (Preclinical, Clinical, PMA), By Indication (Oncology, Neurology, Cardiology, Immunological, Others), By Stage (Preclinical, Clinical, PMA (Post Market Authorization)), By End-User (Medical Device Companies, Biotechnology Companies, Pharmaceutical Companies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRMD3376DR
Last Updated : Dec 04, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Regulatory Affairs Outsourcing Market Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    1. Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    9. U.S.
      1. By Service
        1. Introduction
          1. Service By Value
        2. Regulatory Consulting
          1. By Value
          2. Strategy & Development Planning
            1. Strategy & Development Planning By Value
          3. QA Consulting
            1. QA Consulting By Value
          4. Others
            1. Others By Value
        3. Regulatory Writing and Publishing
          1. By Value
        4. Legal Representation
          1. By Value
        5. Product Registration and Clinical Trial Applications
          1. By Value
        6. Other Services
          1. By Value
        7. Speed Pedelecs
          1. By Value
      2. By Company Size
        1. Introduction
          1. Company Size By Value
        2. Small
          1. By Value
        3. Medium
          1. By Value
        4. Large
          1. By Value
      3. By Categories
        1. Introduction
          1. Categories By Value
        2. Drugs
          1. By Value
        3. Biologics
          1. By Value
        4. Medical devices
          1. By Value
      4. By Product Stage
        1. Introduction
          1. Product Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Oncology
          1. By Value
        3. Neurology
          1. By Value
        4. Cardiology
          1. By Value
        5. Immunological
          1. By Value
        6. Others
          1. By Value
      6. By Stage
        1. Introduction
          1. Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA (Post Market Authorization)
          1. By Value
      7. By End-User
        1. Introduction
          1. End-User By Value
        2. Medical Device Companies
          1. By Value
        3. Biotechnology Companies
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
    10. Canada
    1. Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    9. U.K.
      1. By Service
        1. Introduction
          1. Service By Value
        2. Regulatory Consulting
          1. By Value
          2. Strategy & Development Planning
            1. Strategy & Development Planning By Value
          3. QA Consulting
            1. QA Consulting By Value
          4. Others
            1. Others By Value
        3. Regulatory Writing and Publishing
          1. By Value
        4. Legal Representation
          1. By Value
        5. Product Registration and Clinical Trial Applications
          1. By Value
        6. Other Services
          1. By Value
        7. Speed Pedelecs
          1. By Value
      2. By Company Size
        1. Introduction
          1. Company Size By Value
        2. Small
          1. By Value
        3. Medium
          1. By Value
        4. Large
          1. By Value
      3. By Categories
        1. Introduction
          1. Categories By Value
        2. Drugs
          1. By Value
        3. Biologics
          1. By Value
        4. Medical devices
          1. By Value
      4. By Product Stage
        1. Introduction
          1. Product Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Oncology
          1. By Value
        3. Neurology
          1. By Value
        4. Cardiology
          1. By Value
        5. Immunological
          1. By Value
        6. Others
          1. By Value
      6. By Stage
        1. Introduction
          1. Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA (Post Market Authorization)
          1. By Value
      7. By End-User
        1. Introduction
          1. End-User By Value
        2. Medical Device Companies
          1. By Value
        3. Biotechnology Companies
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
    10. Germany
    11. France
    12. Spain
    13. Italy
    14. Russia
    15. Nordic
    16. Benelux
    17. Rest of Europe
    1. Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    9. China
      1. By Service
        1. Introduction
          1. Service By Value
        2. Regulatory Consulting
          1. By Value
          2. Strategy & Development Planning
            1. Strategy & Development Planning By Value
          3. QA Consulting
            1. QA Consulting By Value
          4. Others
            1. Others By Value
        3. Regulatory Writing and Publishing
          1. By Value
        4. Legal Representation
          1. By Value
        5. Product Registration and Clinical Trial Applications
          1. By Value
        6. Other Services
          1. By Value
        7. Speed Pedelecs
          1. By Value
      2. By Company Size
        1. Introduction
          1. Company Size By Value
        2. Small
          1. By Value
        3. Medium
          1. By Value
        4. Large
          1. By Value
      3. By Categories
        1. Introduction
          1. Categories By Value
        2. Drugs
          1. By Value
        3. Biologics
          1. By Value
        4. Medical devices
          1. By Value
      4. By Product Stage
        1. Introduction
          1. Product Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Oncology
          1. By Value
        3. Neurology
          1. By Value
        4. Cardiology
          1. By Value
        5. Immunological
          1. By Value
        6. Others
          1. By Value
      6. By Stage
        1. Introduction
          1. Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA (Post Market Authorization)
          1. By Value
      7. By End-User
        1. Introduction
          1. End-User By Value
        2. Medical Device Companies
          1. By Value
        3. Biotechnology Companies
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
    10. Korea
    11. Japan
    12. India
    13. Australia
    14. Taiwan
    15. South East Asia
    16. Rest of Asia-Pacific
    1. Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    9. UAE
      1. By Service
        1. Introduction
          1. Service By Value
        2. Regulatory Consulting
          1. By Value
          2. Strategy & Development Planning
            1. Strategy & Development Planning By Value
          3. QA Consulting
            1. QA Consulting By Value
          4. Others
            1. Others By Value
        3. Regulatory Writing and Publishing
          1. By Value
        4. Legal Representation
          1. By Value
        5. Product Registration and Clinical Trial Applications
          1. By Value
        6. Other Services
          1. By Value
        7. Speed Pedelecs
          1. By Value
      2. By Company Size
        1. Introduction
          1. Company Size By Value
        2. Small
          1. By Value
        3. Medium
          1. By Value
        4. Large
          1. By Value
      3. By Categories
        1. Introduction
          1. Categories By Value
        2. Drugs
          1. By Value
        3. Biologics
          1. By Value
        4. Medical devices
          1. By Value
      4. By Product Stage
        1. Introduction
          1. Product Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Oncology
          1. By Value
        3. Neurology
          1. By Value
        4. Cardiology
          1. By Value
        5. Immunological
          1. By Value
        6. Others
          1. By Value
      6. By Stage
        1. Introduction
          1. Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA (Post Market Authorization)
          1. By Value
      7. By End-User
        1. Introduction
          1. End-User By Value
        2. Medical Device Companies
          1. By Value
        3. Biotechnology Companies
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
    10. Turkey
    11. Saudi Arabia
    12. South Africa
    13. Egypt
    14. Nigeria
    15. Rest of MEA
    1. Introduction
    2. By Service
      1. Introduction
        1. Service By Value
      2. Regulatory Consulting
        1. By Value
        2. Strategy & Development Planning
          1. Strategy & Development Planning By Value
        3. QA Consulting
          1. QA Consulting By Value
        4. Others
          1. Others By Value
      3. Regulatory Writing and Publishing
        1. By Value
      4. Legal Representation
        1. By Value
      5. Product Registration and Clinical Trial Applications
        1. By Value
      6. Other Services
        1. By Value
      7. Speed Pedelecs
        1. By Value
    3. By Company Size
      1. Introduction
        1. Company Size By Value
      2. Small
        1. By Value
      3. Medium
        1. By Value
      4. Large
        1. By Value
    4. By Categories
      1. Introduction
        1. Categories By Value
      2. Drugs
        1. By Value
      3. Biologics
        1. By Value
      4. Medical devices
        1. By Value
    5. By Product Stage
      1. Introduction
        1. Product Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Oncology
        1. By Value
      3. Neurology
        1. By Value
      4. Cardiology
        1. By Value
      5. Immunological
        1. By Value
      6. Others
        1. By Value
    7. By Stage
      1. Introduction
        1. Stage By Value
      2. Preclinical
        1. By Value
      3. Clinical
        1. By Value
      4. PMA (Post Market Authorization)
        1. By Value
    8. By End-User
      1. Introduction
        1. End-User By Value
      2. Medical Device Companies
        1. By Value
      3. Biotechnology Companies
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
    9. Brazil
      1. By Service
        1. Introduction
          1. Service By Value
        2. Regulatory Consulting
          1. By Value
          2. Strategy & Development Planning
            1. Strategy & Development Planning By Value
          3. QA Consulting
            1. QA Consulting By Value
          4. Others
            1. Others By Value
        3. Regulatory Writing and Publishing
          1. By Value
        4. Legal Representation
          1. By Value
        5. Product Registration and Clinical Trial Applications
          1. By Value
        6. Other Services
          1. By Value
        7. Speed Pedelecs
          1. By Value
      2. By Company Size
        1. Introduction
          1. Company Size By Value
        2. Small
          1. By Value
        3. Medium
          1. By Value
        4. Large
          1. By Value
      3. By Categories
        1. Introduction
          1. Categories By Value
        2. Drugs
          1. By Value
        3. Biologics
          1. By Value
        4. Medical devices
          1. By Value
      4. By Product Stage
        1. Introduction
          1. Product Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Oncology
          1. By Value
        3. Neurology
          1. By Value
        4. Cardiology
          1. By Value
        5. Immunological
          1. By Value
        6. Others
          1. By Value
      6. By Stage
        1. Introduction
          1. Stage By Value
        2. Preclinical
          1. By Value
        3. Clinical
          1. By Value
        4. PMA (Post Market Authorization)
          1. By Value
      7. By End-User
        1. Introduction
          1. End-User By Value
        2. Medical Device Companies
          1. By Value
        3. Biotechnology Companies
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
    10. Mexico
    11. Argentina
    12. Chile
    13. Colombia
    14. Rest of LATAM
    1. Regulatory Affairs Outsourcing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Accell Clinical Research, LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GenPact Ltd
    3. Criterium, Inc
    4. Promedica International
    5. WuXi AppTec, Inc
    6. Medpace
    7. Charles River Laboratories International, Inc
    8. ICON plc
    9. Covance
    10. PAREXEL
    11. International Corporation, Inc
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Healthcare Regulatory Affairs Outsourcing Market Size The global healthcare regulatory affairs outsourcing market size was valued at USD 7.68 billion in 2023 and is projected to reach a value of USD 15.11 billion by 2032, registering a CAGR of 8% du
Buy Now
Global Report
Medical Affairs Outsourcing Market Size The global medical affairs outsourcing market size was valued at USD 1.53 billion in 2022 and is projected to reach from USD 1.71 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 11.9% du
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :